PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Apyx Medical Corporation (APYX)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS03837C1062
CUSIP03837C106
SectorHealthcare
IndustryMedical Devices

Highlights

Market Cap$53.35M
EPS (TTM)-$0.66
Total Revenue (TTM)$58.74M
Gross Profit (TTM)$27.27M
EBITDA (TTM)-$19.98M
Year Range$1.21 - $7.97
Target Price$3.63
Short %1.24%
Short Ratio5.21

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Apyx Medical Corporation

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Apyx Medical Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%10.00%2024FebruaryMarchAprilMayJune
-35.57%
14.86%
APYX (Apyx Medical Corporation)
Benchmark (^GSPC)

S&P 500

Returns By Period

Apyx Medical Corporation had a return of -40.84% year-to-date (YTD) and -77.60% in the last 12 months. Over the past 10 years, Apyx Medical Corporation had an annualized return of -9.42%, while the S&P 500 had an annualized return of 10.86%, indicating that Apyx Medical Corporation did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date-40.84%13.65%
1 month8.40%3.82%
6 months-31.71%15.17%
1 year-77.60%24.08%
5 years (annualized)-24.43%13.46%
10 years (annualized)-9.42%10.86%

Monthly Returns

The table below presents the monthly returns of APYX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-14.50%-6.25%-35.24%5.15%15.38%-40.84%
202324.79%11.30%-11.38%18.06%86.18%-20.54%11.13%-16.64%-31.33%-28.44%3.06%11.02%11.97%
2022-10.30%-12.00%-35.47%-42.27%61.01%-3.46%61.43%-39.43%-21.64%11.36%-64.80%32.95%-81.75%
202129.03%12.49%-7.56%4.87%-3.36%5.31%-12.71%31.22%17.27%3.25%-6.08%-4.54%78.06%
2020-10.28%-20.29%-40.66%-5.29%30.59%25.00%-19.10%2.23%2.61%27.81%27.08%-5.88%-14.89%
201933.80%-19.03%-10.11%-20.92%20.84%11.44%7.74%-1.80%-4.78%-2.51%20.91%6.02%30.56%
2018-8.46%3.78%20.24%17.51%12.32%10.97%11.03%10.56%32.96%-25.77%34.16%-8.35%149.23%
20175.29%-15.61%-16.30%1.12%-23.33%19.32%2.43%-5.93%42.02%15.38%-24.87%-11.26%-27.58%
20164.76%-14.09%-11.64%17.96%-19.29%3.14%12.80%122.16%26.76%5.76%-22.14%-16.32%70.95%
2015-3.53%-4.79%-29.29%29.62%-6.71%-3.46%-17.20%-4.76%-11.36%-2.56%2.11%8.25%-42.93%
201429.30%13.31%23.81%1.28%16.96%-21.43%7.99%8.16%-5.90%-1.25%-0.36%-6.27%71.16%
201313.64%-2.55%23.13%-1.52%1.85%-10.88%1.69%0.33%-6.31%-6.38%-20.42%2.33%-11.16%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of APYX is 11, indicating that it is in the bottom 11% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.


The Risk-Adjusted Performance Rank of APYX is 1111
APYX (Apyx Medical Corporation)
The Sharpe Ratio Rank of APYX is 1313Sharpe Ratio Rank
The Sortino Ratio Rank of APYX is 99Sortino Ratio Rank
The Omega Ratio Rank of APYX is 1111Omega Ratio Rank
The Calmar Ratio Rank of APYX is 66Calmar Ratio Rank
The Martin Ratio Rank of APYX is 1515Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Apyx Medical Corporation (APYX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


APYX
Sharpe ratio
The chart of Sharpe ratio for APYX, currently valued at -0.72, compared to the broader market-2.00-1.000.001.002.003.00-0.72
Sortino ratio
The chart of Sortino ratio for APYX, currently valued at -1.21, compared to the broader market-4.00-2.000.002.004.006.00-1.21
Omega ratio
The chart of Omega ratio for APYX, currently valued at 0.85, compared to the broader market0.501.001.502.000.85
Calmar ratio
The chart of Calmar ratio for APYX, currently valued at -0.79, compared to the broader market0.002.004.006.00-0.79
Martin ratio
The chart of Martin ratio for APYX, currently valued at -1.21, compared to the broader market0.0010.0020.0030.00-1.21
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.20, compared to the broader market-2.00-1.000.001.002.003.002.20
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.12, compared to the broader market-4.00-2.000.002.004.006.003.12
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.39, compared to the broader market0.501.001.502.001.39
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.76, compared to the broader market0.002.004.006.001.76
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 8.26, compared to the broader market0.0010.0020.0030.008.26

Sharpe Ratio

The current Apyx Medical Corporation Sharpe ratio is -0.72. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Apyx Medical Corporation with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.002024FebruaryMarchAprilMayJune
-0.72
2.20
APYX (Apyx Medical Corporation)
Benchmark (^GSPC)

Dividends

Dividend History


Apyx Medical Corporation doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%2024FebruaryMarchAprilMayJune
-97.93%
0
APYX (Apyx Medical Corporation)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Apyx Medical Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Apyx Medical Corporation was 99.54%, occurring on Jul 15, 1999. The portfolio has not yet recovered.

The current Apyx Medical Corporation drawdown is 97.93%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.54%May 27, 19862030Jul 15, 1999
-0.87%May 16, 19861May 16, 19862May 20, 19863

Volatility

Volatility Chart

The current Apyx Medical Corporation volatility is 11.39%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%2024FebruaryMarchAprilMayJune
11.39%
2.51%
APYX (Apyx Medical Corporation)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Apyx Medical Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items